LA JOLLA, CA, Jan. 26, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (GRI) (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of immune cell modulators for ...
(MENAFN- GlobeNewsWire - Nasdaq) Issued Claims Protect Distinct Molecular Designs with Broad Therapeutic Potential Across Inflammatory, Fibrotic, and Autoimmune Diseases LA JOLLA, CA, Jan. 26, 2026 ...
Issued Claims Protect Distinct Molecular Designs with Broad Therapeutic Potential Across Inflammatory, Fibrotic, and Autoimmune Diseases LA JOLLA, CA, Jan. 26, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc.
The MarketWatch News Department was not involved in the creation of this content. LAS VEGAS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- For this year's Consumer Electronics Show in Las Vegas, HYTE is returning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results